Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Recruiting 4Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gynecologic 1Gastrointestinal 1

Conditions

Right Sided Colon Cancer 1Ovarian Neoplasms 1Oligometastatic Non-small Cell Lung Cancer (NSCLC) 1Fallopian Tube Neoplasms 1Carcinosarcoma 1

Interventions

Specimen Handling 481pembrolizumab 454Magnetic Resonance Spectroscopy 419Carboplatin 321Cyclophosphamide 314Biopsy 272Cisplatin 264Radiotherapy 239Paclitaxel 226Gemcitabine 222Bevacizumab 212Nivolumab 189fludarabine 183venetoclax 172Drug Therapy 165Dexamethasone 157Blood Specimen Collection 156Oxaliplatin 154Injections 152Capecitabine 152Fluorouracil 144Docetaxel 142Standard of Care 136Radiosurgery 136Rituximab 125Pemetrexed 115durvalumab 113atezolizumab 110Leucovorin 110Radiation 105

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Minimally Invasive Surgical Procedures × 1 year × Clear all
NCT05646316 2026-03-27

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

NRG Oncology

Phase 3 Recruiting
428 enrolled
Sarcoma

Carcinosarcoma

NCT04575935 2026-03-05

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

M.D. Anderson Cancer Center

Phase 3 Recruiting
580 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06329102 2025-09-15

RCC

Haukeland University Hospital

Recruiting
1,000 enrolled
Gastrointestinal

Right Sided Colon Cancer

NCT06840782 2025-09-15

OliGRAIL

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting
124 enrolled
Thoracic

Oligometastatic Non-small Cell Lung Cancer (NSCLC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡